Company Overview and News
Lennar Corporation (LEN - Free Report) is likely to sell its real estate investment management unit, Rialto Capital, to a private-equity firm, Stone Point Capital LLC, per the report by Wall Street Journal. However, Lennar’s spokesperson refrained from commenting on the same. In April, the Miami-based homebuilder had already indicated strategic alternatives to improve the future path of Rialto, to drive efficiencies and cash flow.
AWI AFI TOL LEN LEN.B
D.R. Horton, Inc.’s (DHI - Free Report) shares declined 3.1% yesterday, after the company delivered preliminary fiscal fourth-quarter 2018 results. The company, which is set to report fiscal fourth-quarter results on Nov 8, stated that homes closed in the quarter increased 11% to 14,674, lagging the Zacks Consensus Estimate of 15,084. For the full year, homes closed increased 13% to 51,857 and 14% in value to $15.
TOL LEN DHI LEN.B NCS
(Reuters) - U.S. homebuilder D.R. Horton Inc (DHI.N) on Tuesday forecast fiscal 2018 home sales and orders below Wall Street estimates, as rising home prices and mortgage rates hurt ordinary Americans’ ability to borrow.
Lennar Corporation (LEN - Free Report) announced that it will develop a new golf and country club community, Babcock National, situated northeast of Founders Square across Lake Babcock. The community will be located in the master-planned development in southwest Florida, Babcock Ranch. Through Babcock National, Lennar will offer 18 home designs, a mix of multi-family and single-family homes, with its signature Everything's Included program that offers a high level of standard features, which are already included in the price of the homes.
CCS LEN PHM DHI LEN.B
While the stock market continues to hit new all-time highs, the volatility in interest rate explodes, and political theatrics consume most media outlets, the housing market has had a very stealth slowdown that should start to be a cause for concern. The housing market has gone from a "yellow light" to a "red light" based on the recent data, and the housing-related equities support that view with the iShares U.
LOW HD KBH TOL DHI LEN ITB
2018-10-05 investorplace - 1
Wednesday was the second winning day for the S&P 500 this week, but like the other two trading sessions, it has been a struggle. All the indices once again peeled back from intraday highs, with the bulls unwilling to keep the pressure on through the closing bell.
BAC IP KMI LEN INPAP AMD KMR KMRFZ CVB
2018-10-03 investorplace - 1
While major U.S. indices closed near flat today, we saw gold prices fall and steep declines in volatility and bonds. It was interesting behavior for these safe-haven and market measurement securities to tumble in such a fashion. Let’s lead off with that in our top stock trades.
BAC AMZN JPM TLT CAT GOOGL TWTR LEN AMD GOOG
October 3, 2018: Here are four stocks trading with heavy volume among 121 equities making new 52-week lows in Wednesday’s session. On the NYSE decliners led advancers by about 1.45 to 1, and on the Nasdaq, advancers led decliners by about 1.6 to 1.
GOV SIR LEN RAD CENX LEN.B GOVNI
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to LEN / Lennar Corp. on message board site Silicon Investor.
as of ET